Paratus Clinical

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Obesity1 trial
• Type 2 diabetes1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Novo Nordisk A/S2 trials

Closed trials

• Completed

  A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

  NCT06534411· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight

  NCT06326060· Phase 2· Novo Nordisk A/S· Source